NCT03602937View on ClinicalTrials.gov

Evaluation of Renastep

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 17, 2018

Primary Completion Date

December 1, 2019

Study Completion Date

December 1, 2019

Conditions
Chronic Kidney DiseasesRenal Disease
Interventions
DIETARY_SUPPLEMENT

Renastep

Renastep is a ready-to-use, high energy, low volume liquid renal specific feed that can be administered enterally via tube or oral consumption.

Trial Locations (3)

S016 6YD

Southampton Children's Hospital, Southampton

L12 2AP

Alder Hey Children's Hospital, Liverpool

B4 6NH

Birmingham Children's Hospital, Birmingham

All Listed Sponsors
lead

Vitaflo International, Ltd

INDUSTRY

NCT03602937 - Evaluation of Renastep | Biotech Hunter | Biotech Hunter